Shanghai Customs reported today that last year, Shanghai Port processed the import of 504,400 batches of legally inspected consumer goods, with a total value of 20.378 billion yuan, accounting for over 40% of the national total and maintaining its position as the largest import hub in China. Beyond the mandatory inspection catalog, Shanghai Customs conducted spot checks on ten types of consumer goods closely related to consumers, including infant clothing, imitation jewelry, walkie-talkies, and student stationery. Among these, 34 batches were found to have safety non-compliances, and all necessary corrective measures have been implemented. In imported food-contact products, Shanghai Customs detected excessive migration of elements such as lead, nickel, and chromium, as well as超标 levels of aromatic primary amines. In imported clothing, issues were identified with formaldehyde content, pH levels, drawstrings, and color fastness. Imported coatings were found to have超标 volatile organic compounds (VOCs) and formaldehyde content. Imported toys showed non-compliance with phthalate plasticizer standards, while imported medical devices exhibited不合格 cytotoxicity in absorbable surgical sutures. A relevant official stated, "Through big data analysis, Shanghai Customs precisely identifies high-risk countries (regions), high-risk brands, and high-risk items, dynamically adjusts inspection intensity, and enhances inspection accuracy with targeted measures. This ensures strict quality and safety controls while continuously promoting the optimization of the import consumer goods structure." Shanghai Port is China's most critical entry point for medical devices and their components, handling approximately half of the national business volume. Shanghai Customs pioneered a pilot program for grading and classifying the quality and safety risks of imported medical devices. For instance, based on risk assessment results, the inspection ratio for imported medical devices is dynamically adjusted, enabling targeted supervision of high-risk products and expedited clearance for low-risk items, thereby invigorating the domestic medical device market. By focusing on urgently needed production materials for the medical device industry, iterative facilitation measures for inspection and supervision have been introduced, optimizing the "enterprise + product" whitelist model to advance the domestic substitution initiative and the localization of overseas high-end medical devices already on the market. Since the beginning of this year, over 5,400 batches of low-risk medical devices have benefited from these measures, with clearance times reduced by 80% compared to the same period last year, benefiting more than 180 import enterprises, including Johnson & Johnson, Becton Dickinson, Abbott, Boston Scientific, and Medtronic. For high-quality medical devices urgently needed in domestic clinical settings and by patients, innovative inspection and supervision models such as compliance assurance, conformity verification, and acceptance of inspection results have been adopted to ensure safe and smooth imports, benefiting a wide range of domestic patients. Taking the leadless cardiac pacemaker, a star exhibit at the China International Import Expo, as an example, Shanghai Customs has facilitated the rapid clearance of over 3,000 such pacemakers, which have subsequently been distributed to more than 500 hospitals across China. Last year, Shanghai Customs, in collaboration with the Shanghai Municipal Commission of Commerce, launched facilitation measures for the inspection of first-import consumer goods. The "enterprise + product" whitelist covers a full range of first-import consumer goods, including apparel, toys, and home appliances. The commerce department recommends key enterprises and new product lists, while customs conducts pre-import safety assessments, enabling information sharing and joint risk prevention. A tiered inspection mechanism, including "compliance assurance, assessment, and conformity verification," is applied to first-import consumer goods. To date, these facilitation measures have benefited 34 multinational brand headquarters, 60 internationally renowned brands, and nearly 30,000 new first-import products. The clearance time for 15,400 batches of first-import new products has been reduced by 80%, allowing them to quickly enter the market. Driven by these favorable policies, from January to February this year, Shanghai imported 5,801 batches of first-import consumer goods with a value of 130 million yuan, with monthly average batches and values increasing by 1.4 times and 1.2 times year-on-year, respectively. This year, Shanghai Customs will continue to iteratively optimize related measures: in the medical device sector, exploring "regulatory grading and scenario classification" to build a differentiated supervision system covering all categories; in the first-import economy, expanding and accelerating facilitation measures, optimizing the whitelist application process, and increasing the frequency of new product recognition.